104 related articles for article (PubMed ID: 8721090)
21. [Palliative chemotherapy in metastatic and locally advanced gastrointestinal tumor].
Dippold W
Zentralbl Chir; 1998; 123(6):722-4. PubMed ID: 9703647
[TBL] [Abstract][Full Text] [Related]
22. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
Nakamori M; Iwahashi M; Nakamura M; Yamaue H
J Surg Oncol; 2003 Sep; 84(1):10-6. PubMed ID: 12949985
[TBL] [Abstract][Full Text] [Related]
23. [In vitro chemosensitivity test using collagen gel matrix for human gastric carcinomas].
Oyama S; Kinoshita K; Ninomiya I; Yonemura Y; Miyazaki I; Tanaka M; Sasaki T
Nihon Geka Gakkai Zasshi; 1991 Oct; 92(10):1444-50. PubMed ID: 1961182
[TBL] [Abstract][Full Text] [Related]
24. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
[TBL] [Abstract][Full Text] [Related]
25. [The evaluation of adenosine triphosphate bioluminescence assay for chemosensitivity testing of ovarian cancer cell line].
Shi W; Gu M; Liang L
Zhonghua Fu Chan Ke Za Zhi; 1996 Feb; 31(2):79-82. PubMed ID: 8758798
[TBL] [Abstract][Full Text] [Related]
26. Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response.
Ness RB; Wisniewski SR; Eng H; Christopherson W
Anticancer Res; 2002; 22(2B):1145-9. PubMed ID: 12168915
[TBL] [Abstract][Full Text] [Related]
27. [Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer].
Tian HM; Shi XY; Fu J; Chao DY; Zhang K; Wu LY; Wang JW; Zhang W
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):296-8. PubMed ID: 15996325
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of succinic dehydrogenase inhibition test with adenosine triphosphate inhibition assay for human solid tumors as in vitro chemosensitivity tests].
Saeki T; Jinushi K; Kim R; Kirihara Y; Takagami S; Nishiyama M; Saeki K; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1989 May; 16(5):2025-30. PubMed ID: 2730092
[TBL] [Abstract][Full Text] [Related]
29. [Individualized tumor response assay].
Kubota T
Gan To Kagaku Ryoho; 2008 Feb; 35(2):174-7. PubMed ID: 18281751
[TBL] [Abstract][Full Text] [Related]
30. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085
[TBL] [Abstract][Full Text] [Related]
31. Adenosine triphosphate-based chemotherapy response assay (ATP-CRA)-guided platinum-based 2-drug chemotherapy for unresectable nonsmall-cell lung cancer.
Moon YW; Choi SH; Kim YT; Sohn JH; Chang J; Kim SK; Park MS; Chung KY; Lee HJ; Kim JH
Cancer; 2007 May; 109(9):1829-35. PubMed ID: 17366594
[TBL] [Abstract][Full Text] [Related]
32. [The experiment and clinical evaluation of chemosensitivity test for esophageal and gastric cancer by ATP assay using endoscopic biopsy].
Kawano K
Nihon Geka Gakkai Zasshi; 1992 Mar; 93(3):232-40. PubMed ID: 1513305
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy in the management of malignant gastrointestinal disease.
Canfield V; Mortimer JE
Gastroenterol Clin North Am; 1992 Sep; 21(3):695-714. PubMed ID: 1516963
[TBL] [Abstract][Full Text] [Related]
34. [Chemosensitivity test-based chemotherapy for brain tumors].
Fujimoto S
Nihon Rinsho; 2005 Sep; 63 Suppl 9():456-9. PubMed ID: 16201564
[No Abstract] [Full Text] [Related]
35. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
[TBL] [Abstract][Full Text] [Related]
36. [Chemosensitivity test for advanced and recurrent gastric cancer].
Kubota T
Nihon Rinsho; 2001 Apr; 59 Suppl 4():415-9. PubMed ID: 11424417
[No Abstract] [Full Text] [Related]
37. Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements.
Kurbacher CM; Cree IA
Methods Mol Med; 2005; 110():101-20. PubMed ID: 15901931
[TBL] [Abstract][Full Text] [Related]
38. [Clonogenic assays in the evaluation of antitumor chemotherapy].
Aapro MS
Schweiz Med Wochenschr; 1987 Aug; 117(34):1266-9. PubMed ID: 3313688
[TBL] [Abstract][Full Text] [Related]
39. [Predictive and prognostic factors in the neoadjuvant/adjuvant therapy of gastrointestinal tumors: wishful thinking or reality?].
Vallböhmer D; Lenz HJ
Zentralbl Chir; 2006 Apr; 131(2):148-56. PubMed ID: 16612782
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
Itaya M; Yoshimoto J; Kojima K; Kawasaki S
Methods Mol Med; 2005; 110():213-27. PubMed ID: 15901938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
